# A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism

> **NCT06867913** · NA · COMPLETED · sponsor: **S.LAB (SOLOWAYS)** · enrollment: 40 (actual)

## Conditions studied

- Autoimmune Thyroiditis

## Interventions

- **DIETARY_SUPPLEMENT:** Supplement groupx
- **DIETARY_SUPPLEMENT:** Supplement groupx

## Key facts

- **NCT ID:** NCT06867913
- **Lead sponsor:** S.LAB (SOLOWAYS)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-15
- **Primary completion:** 2024-12-26
- **Final completion:** 2025-02-21
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06867913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06867913, "A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06867913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*